CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$20,948
-12.8%
13,9650.0%0.00%
Q1 2023$24,020
+49.6%
13,9650.0%0.00%
Q4 2022$16,060
-56.6%
13,9650.0%0.00%
Q3 2022$37,000
+19.4%
13,9650.0%0.00%
Q2 2022$31,000
-53.0%
13,9650.0%0.00%
Q1 2022$66,000
-22.4%
13,9650.0%0.00%
Q4 2021$85,000
-15.8%
13,9650.0%0.00%
Q3 2021$101,000
+14.8%
13,9650.0%0.00%
Q2 2021$88,00013,9650.00%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Shay Capital LLC 309,178$671,0000.14%
Taylor & Morgan Wealth Management, LLC 17,086$37,0000.04%
Ikarian Capital, LLC 81,089$176,0000.03%
Corundum Group, Inc. 19,600$43,0000.03%
M Holdings Securities, Inc. 70,909$154,0000.02%
Praetorian Wealth Management, Inc. 15,000$32,0000.01%
Western Wealth Management, LLC 27,050$115,0000.01%
Mirae Asset Global Investments Co., Ltd. 1,073,765$2,330,0000.01%
Virtu Financial LLC 16,063$35,0000.00%
SeaCrest Wealth Management, LLC 6,800$15,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders